Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines

Efficient control of influenza A infection can potentially be achieved through the development of broad-spectrum vaccines. Recombinant proteins incorporating conserved influenza A virus peptides are one of the platforms for the development of cross-protective influenza vaccines. We constructed a recombinant protein Flg-HA2-2-4M2ehs, in which the extracellular domain of the M2 protein (M2e) and the sequence (aa76-130) of the second subunit of HA (HA2) were used as target antigens. In this study, we investigated the ability of the Flg-HA2-2-4M2ehs protein to activate innate immunity and stimulate the formation of T-cell response in mice of different genetic lines after intranasal immunization. Our studies showed that the Flg-HA2-2-4M2ehs protein was manifested in an increase in the relative content of neutrophils, monocytes, and interstitial macrophages, against the backdrop of a decrease in the level of dendritic cells and increased expression in the CD86 marker. In the lungs of BALB/c mice, immunization with the Flg-HA2-2-4M2ehs protein induced the formation of antigen-specific CD4+ and CD8+ effector memory T cells, producing TNF-α. In mice C57Bl/6, the formation of antigen-specific effector CD8+ T cells, predominantly producing IFN-γ+, was demonstrated. The data obtained showed the formation of CD8+ and CD4+ effector memory T cells expressing the CD107a.

[1]  Mingkai Xu,et al.  A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection , 2021, bioRxiv.

[2]  W. Mitzner,et al.  Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model , 2021, Journal of Virology.

[3]  D. Lapuente,et al.  T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine , 2021, Viruses.

[4]  N. Lukacs,et al.  Harnessing Cellular Immunity for Vaccination against Respiratory Viruses , 2020, Vaccines.

[5]  J. de Jonge,et al.  Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets , 2020, Communications biology.

[6]  B. Seong,et al.  Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection , 2020, Expert opinion on drug discovery.

[7]  Chi‐Huey Wong,et al.  Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes , 2020, Proceedings of the National Academy of Sciences.

[8]  Deepali Kumar,et al.  T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients , 2020, Scientific Reports.

[9]  Bin Zhou,et al.  Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine , 2020, medRxiv.

[10]  А. А. Ковалева,et al.  Интраназальная иммунизация рекомбинантным белком на основе М2е-пептида и фрагмента второй субъединицы гемагглютинина вирусов гриппа А индуцирует кросс-протективный гуморальный и Т-клеточный ответ у мышей , 2020 .

[11]  J. Taubenberger,et al.  Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study , 2020, npj Vaccines.

[12]  S. Prakash,et al.  Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4+ TEM Cells in Asymptomatic Individuals and Protect from Ocular Herpes Infection and Disease in “Humanized” HLA-DR Transgenic Mice , 2020, Journal of Virology.

[13]  K. Ladell,et al.  Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells , 2019, The Journal of Immunology.

[14]  X. Saelens The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines , 2019, The Journal of infectious diseases.

[15]  P. Velilla,et al.  An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression , 2019, PloS one.

[16]  N. Ravin,et al.  Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine , 2018, PloS one.

[17]  J. Mascola,et al.  Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem. , 2018, Cold Spring Harbor perspectives in biology.

[18]  N. Ravin,et al.  Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes , 2018, Journal of Biomedical Science.

[19]  M. Savic,et al.  Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy , 2017, PloS one.

[20]  Catharine I Paules,et al.  The Pathway to a Universal Influenza Vaccine. , 2017, Immunity.

[21]  J. Mascola,et al.  Preferential induction of cross-group influenza A hemagglutinin stem–specific memory B cells after H7N9 immunization in humans , 2017, Science Immunology.

[22]  W. Fiers,et al.  M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection , 2017, Mucosal Immunology.

[23]  H. Frijlink,et al.  Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine , 2017, Medicine.

[24]  W. Fiers,et al.  M2-based influenza vaccines: recent advances and clinical potential , 2017, Expert review of vaccines.

[25]  S. Kent,et al.  Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection? , 2017, Front. Immunol..

[26]  J. Donnelly,et al.  Universal influenza vaccines: Shifting to better vaccines , 2016, Vaccine.

[27]  M. Potapchuk,et al.  A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity , 2016, Acta naturae.

[28]  L. Que,et al.  A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues , 2016, PloS one.

[29]  P. Thomas,et al.  Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection , 2016, Front. Immunol..

[30]  D. Tscharke,et al.  Sizing up the key determinants of the CD8+ T cell response , 2015, Nature Reviews Immunology.

[31]  Yu-Jin Kim,et al.  Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines , 2015, Immune network.

[32]  Fang Fang,et al.  Protection against Multiple Subtypes of Influenza Viruses by Virus-Like Particle Vaccines Based on a Hemagglutinin Conserved Epitope , 2015, BioMed research international.

[33]  G. Rimmelzwaan,et al.  Virus-specific T cells as correlate of (cross-)protective immunity against influenza. , 2015, Vaccine.

[34]  S. Shin,et al.  DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8+ T cell responses , 2014, Clinical and experimental vaccine research.

[35]  Jonathan J Deeks,et al.  Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.

[36]  G. Rimmelzwaan,et al.  Clearance of influenza virus infections by T cells: risk of collateral damage? , 2013, Current opinion in virology.

[37]  I. Wilson,et al.  A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin , 2012, Journal of Virology.

[38]  T. Strutt,et al.  Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. , 2012, The Journal of clinical investigation.

[39]  Deborah M. Brown,et al.  Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection , 2012, Journal of Virology.

[40]  J. Oxford,et al.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.

[41]  A. Osterhaus,et al.  Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines , 2011, Journal of biomedicine & biotechnology.

[42]  W. Fiers,et al.  Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection , 2011, The Journal of Immunology.

[43]  R. Varadarajan,et al.  Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge , 2010, Proceedings of the National Academy of Sciences.

[44]  A. Rosato,et al.  Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer , 2010, International reviews of immunology.

[45]  R. Hai,et al.  Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins , 2010, PLoS pathogens.

[46]  K. Mozdzanowska,et al.  Prospects for Universal Influenza Virus Vaccine , 2006, Emerging infectious diseases.

[47]  A. Jegerlehner,et al.  Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity , 2004, The Journal of Immunology.

[48]  C. Paidas,et al.  GENETIC CONTRIBUTION TO THE SEPTIC RESPONSE IN A MOUSE MODEL , 2002, Shock.

[49]  P. Šebo,et al.  Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin. , 2013, Antiviral research.